All News

After hospital admittance, the number of patients with heart failure who are on 10 or more medications rises.

Pembrolizumab (Keytruda) has demonstrated promising activity when used in combination with chemotherapy or quavonlimab in select patients with nonsquamous non–small cell lung cancer.

Combined nonprofit organization meets accreditation needs of health care providers across the entire continuum of care.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

Like other essential businesses, Village Pharmacy in New Jersey has remained open throughout the COVID-19 pandemic, with the goal of providing the same personalized care as always.

In 2019, the independent community pharmacy industry represented 35% of all retail pharmacies in the United States with a $73.7 billion marketplace, according to the NCPA’s recently released 2020 NCPA Digest.

IG, a 25-year-old female patient, approaches the pharmacy counter with an arm full of OTC products. She tells her pharmacist that she is there to pick up the antibiotic cephalexin for an upper respiratory infection.

Lennartz said it’s important that pharmacists are properly reimbursed for the administration of many common immunizations, including the flu vaccine.

Virtual transitions of care services are a valuable and viable opportunity for students to progress to graduation and gain valuable experience in preparation for professional employment.

The Mary Pazdur Award was presented during the JADPRO Live Virtual conference.

Herpes zoster, commonly known as shingles, is often painful and in some cases last more than a year.

Study shows a small increase in the perceived reliability of COVID-19 conspiracies equates to a larger drop in the intention to get vaccinated.

Sirolimus is an mTOR inhibitor immunosuppressant indicated for the prophylaxis of organ rejection.

The FDA action was based on results from the Phase 3 CheckMate -9ER trial evaluating nivolumab in combination with cabozantinib compared with sunitinib among patients with previously untreated advanced RCC.

After a rewarding 40-year career, Pharmacy Quality Solutions CEO Jeff Newell announces intent to retire in 2021.

Dogs and Cats have different blood make-ups and need a specifically calibrated device for glucose monitoring to manage diabetes.

Venetoclax was granted accelerated approval in November 2018, as well as priority review, breakthrough designation, and orphan drug designation.

In a short time, COVID-19 has increased our dependency on technology and pharmaceutical companies are actively investigating this digital transformation.

Top news of the week from Pharmacy Times.

A recent study found that where you live affects the risk of chronic conditions, such as high blood pressure and depression.

Women found to have worse outcomes after a first heart attack than men.

Women diagnosed with cancer as adolescents or young adults can be especially vulnerable to the impact of the disease and its treatment on their ability to work.

A recent study shows an unintended increase from 20% to 60% in the proportion of depressed youth without antidepressant treatment.

Which poisonous chemical was historically infused into chalices to induce vomiting?

Atoltivimab, maftivimab, and odesivimab-ebgn (Inmazeb), a monoclonal antibody cocktail ffor the treatment of adult and pediatric patients with Ebola virus infection, becomes the first drug approved to treat Ebola virus.

The FDA approved an expanded label for for pembrolizumab for adult patients with relapsed or refractory classical Hodgkin lymphoma.

Hospitalized patients with COVID-19 treated with enoxaparin were found to have lower rates of thrombosis, kidney injury, and mortality than patients treated with unfractionated heparin.

Age has been connected to symptom severity and mortality in COVID-19, however, it does not affect susceptibility to infection with the virus.

Although researchers still hope to learn what protection immunoglobulin G antibodies offer against re-infection, this study could have broad implications in the development of a COVID-19 vaccine.

Due to the suboptimal rates of live-attenuated varicella vaccination, outbreaks of varicella-zoster virus still occur, causing incidence of both varicella and herpes zoster.